Archives of Neurology · 2011 · 62 citations · 21 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityClinical ImmunologyInflammationCentral Nervous System ImmunityCytokine BiologyCytokine RegulationHelper T Cell SubsetsNeuroinflammationT Cell ActivationAnti-inflammatory MechanismsCase-control Study DesignGuillain-barré Syndrome PathogenesisOuter Membrane ProteinsT Cell Activation CytokinesTh2 Immune Response
OBJECTIVES: To determine the expression of proinflammatory and anti-inflammatory cytokines in lymphocytes from the progressive and recovery phases of Guillain-Barré syndrome (GBS) after stimulation with Campylobacter jejuni outer membrane proteins. DESIGN: Case-control study. SETTING: Sanjay Gandhi Postgraduate Institute of Medical Sciences. PARTICIPANTS: Sixty-five patients with GBS, 60 age- and sex-matched disease control individuals, and 68 healthy control individuals were included in the study. MAIN OUTCOME MEASURES: Lymphocytes from patients with GBS were stimulated with C jejuni outer membrane proteins, and the levels of different proinflammatory (T(H)1 [helper T cell, subtype 1]) and anti-inflammatory (T(H)2) cytokines were determined by reverse-transcription polymerase chain reaction and enzyme-linked immunosorbent assay. RESULTS: In the progressive phase of the disease, the expressions of interferon γ (IFN-γ), interleukin 1β (IL-1β), tumor necrosis factor (TNF), IL-6, IL-10, and the IFN-γ:IL-4 ratio were significantly upregulated, but expressions of transforming growth factor (TGF)-β1 and IL-4 were lower in patients compared with disease and healthy controls. In contrast, the levels of IFN-γ, IL-1β, TNF, IL-6, IL-10, and the IFN-γ:IL-4 ratio were significantly lower, but TGF-β1 and IL-4 were upregulated in the recovery phase of GBS patients compared with controls. CONCLUSIONS: Upregulation of T(H)1 cytokines in the early disease course may be associated with immune-mediated disease progression due to neuronal inflammation, but upregulation of T(H)2 immune response during the later phase aids recovery from the disease.
21
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
Richard AC Hughes, John Newsom–Davis, G D Perkin et al. · The Lancet · 1978 · 1.1K citations